UF researchers test novel drug to slow Type 1 diabetes
Armed with a new $5.5 million grant from Breakthrough T1D, University of Florida researchers led by Dr. Michael Haller are launching a clinical trial to test whether SAB-142 can safely slow the progression of Type 1 diabetes. He joined FOX 35's Garrett Wymer live over Zoom to discuss his research.
Top Videos
UF researchers test novel drug to slow Type 1 diabetes
Takeaways from Florida 2026 primary election
Trump labels Strait of Hormuz 'new' U.S. territory
Monday morning quarterbacking returns: takeaways from week zero
Alex Vindman discusses campaign for U.S Senate
Are foldable iPhones on the way?
Spooky season begins at the theme parks
Mayra Uribe's plan for Orange County
FOX 35 Severe Thunderstorm Coverage across Central Florida
Myths Vs. Reality on Filing taxes during tax season
PCSO gives updates on Savannah Guthrie's missing mother
Tax season quickly approaching: Do's and Don'ts
Large crowds gather as ICE Protests break out in Downtown Orlando
Orlando officials react: ICE Protests break out in Downtown Orlando
Local Florida Professor weighs in on context of ICE protests
Conservative Political Analyst: Minneapolis ICE shooting was justified
Orlando ICE protests: Analyst backs agent in Minneapolis shooting
Things to do in Orlando on NYE Weekend
Old Dominion, USF speak ahead of 2025 Cure Bowl game
Shop & Drop for Orange County Mayor's Toy Drive
Orange County Mayor's Toy Drive
St. Cloud Police launch drone first responder unit
FOX 35 presents culinary instructor with Care Force award
Florida congressional lawmakers face separate ethics investigations
Congressman Byron Donalds speaks on bid for Florida Governor
